1. Verteporfin disrupts multiple steps of autophagy and regulates p53 to sensitize osteosarcoma cells
   Heena Saini et al, 2021, Cancer Cell International CrossRef
2. Mechanisms of Resistance to Conventional Therapies for Osteosarcoma
   Louise Marchandet et al, 2021, Cancers CrossRef
3. MicroRNA-199a-5p inhibits cisplatin-induced drug resistance via inhibition of autophagy in osteosarcoma cells
   Yusheng Li et al, 2016, Oncology Letters CrossRef
4. Targeting autophagy is a promising therapeutic strategy to overcome chemoresistance and reduce metastasis in osteosarcoma
   Yu‑Xin Liao et al, 2019, International Journal of Oncology CrossRef
5. GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy
   Mihwa Kim et al, 2017, Autophagy CrossRef
6. Differential regulation of autophagy by STAU1 in alveolar rhabdomyosarcoma and non‐transformed skeletal muscle cells
   Shekoufeh Almasi et al, 2021, Cellular Oncology CrossRef
7. Multi-omics analysis based on 3D-bioprinted models innovates therapeutic target discovery of osteosarcoma
   Yixuan Lin et al, 2022, Bioactive Materials CrossRef
8. Dengue-induced autophagy, virus replication and protection from cell death require ER stress (PERK) pathway activation
   E Datan et al, 2016, Cell Death & Disease CrossRef
9. CQ sensitizes human pancreatic cancer cells to gemcitabine through the lysosomal apoptotic pathway via reactive oxygen species
   Zhiping Fu et al, 2018, Molecular Oncology CrossRef
10. Paeoniflorin induces G2/M cell cycle arrest and caspase-dependent apoptosis through the upregulation of Bcl-2 X-associated protein and downregulation of B-cell lymphoma 2 in human osteosarcoma cells
    Li‑Bin Jin et al, 2018, Molecular Medicine Reports CrossRef
11. Nutritional shortage augments cisplatin-effects on murine melanoma cells
    F. Antunes et al, 2018, Chemico-Biological Interactions CrossRef
12. Molecular Mechanisms Underlying Autophagy-Mediated Treatment Resistance in Cancer
    Cally J. Ho et al, 2019, Cancers CrossRef
13. Palladium (II) compounds containing oximes as promising antitumor agents for the treatment of osteosarcoma: An in vitro and in vivo comparative study with cisplatin
    Thales Hebert Regiani Pereira et al, 2024, European Journal of Medicinal Chemistry CrossRef
14. Autophagy in Cisplatin Nephrotoxicity during Cancer Therapy
    Xiaoru Hu et al, 2021, Cancers CrossRef
15. P62: An emerging oncotarget for osteolytic metastasis
    Jing Zhang et al, 2016, Journal of Bone Oncology CrossRef
16. MicroRNA-410 regulates autophagy-related gene ATG16L1 expression and enhances chemosensitivity via autophagy inhibition in osteosarcoma
    Ren Chen et al, 2017, Molecular Medicine Reports CrossRef
17. Analysis of HSP27 and the Autophagy Marker LC3B+ Puncta Following Preoperative Chemotherapy Identifies High-Risk Osteosarcoma Patients
    J. Andrew Livingston et al, 2018, Molecular Cancer Therapeutics CrossRef
18. Regulated cell death and drug resistance in malignant bone tumors
    Günther Richter et al, 2022, Bone Cancer CrossRef
19. Expression and Clinical Implication of Autophagy-Associated Protein p62 in Osteosarcoma
    Hangzhan Ma et al, 2018, Oncology CrossRef
20. Autophagy as a potential target for sarcoma treatment
    Li Min et al, 2017, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
21. Phosphorylated heat shock protein 27 as a potential biomarker to predict the role of chemotherapy-induced autophagy in osteosarcoma response to therapy
    Janice M. Santiago-O’Farrill et al, 2018, Oncotarget CrossRef
22. Role of autophagy in osteosarcoma
    Olivier Camuzard et al, 2019, Journal of Bone Oncology CrossRef
23. Autophagy-mediating microRNAs in cancer chemoresistance
    Yuanming Jing et al, 2020, Cell Biology and Toxicology CrossRef
24. Untangling the complexity of heat shock protein 27 in cancer and metastasis
    Suroor Fatima Rizvi et al, 2023, Archives of Biochemistry and Biophysics CrossRef